On the Application of Flexible Designs When Searching for the Better of Two Anticancer Treatments
暂无分享,去创建一个
[1] H. Schäfer,et al. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections , 2001, Statistics in medicine.
[2] Gernot Wassmer,et al. Planning and Analyzing Adaptive Group Sequential Survival Trials , 2006, Biometrical journal. Biometrische Zeitschrift.
[3] Cyrus R Mehta,et al. Adaptive increase in sample size when interim results are promising: A practical guide with examples , 2011, Statistics in medicine.
[4] G. Wassmer,et al. Comments on the Draft Guidance on “Adaptive Design Clinical Trials for Drugs and Biologics” of the U.S. Food and Drug Administration , 2010, Journal of biopharmaceutical statistics.
[5] M H Gail,et al. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. , 1981, Journal of chronic diseases.
[6] P. Olbert,et al. Metastatic non‐clear cell renal cell carcinoma: current therapeutic options , 2008, BJU international.
[7] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[8] C. Zielinski,et al. Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapy. , 2009, Cancer treatment reviews.
[9] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[10] Myron Chang,et al. Group sequential designs using both type I and type II error probability spending functions , 1998 .
[11] P. Bauer,et al. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections by H. Schäfer and H.‐H. Müller, Statistics in Medicine 2001; 20: 3741–3751 , 2004, Statistics in medicine.
[12] K Desseaux,et al. Flexible two‐stage design with sample size reassessment for survival trials , 2007, Statistics in medicine.
[13] R. Schmidt,et al. Adaptive designs for the one‐sample log‐rank test , 2018, Biometrics.
[14] Yevgen Tymofyeyev,et al. A Review of Available Software and Capabilities for Adaptive Designs , 2014 .
[15] M. Posch,et al. Adaptive Survival Trials , 2014, 1405.1569.
[16] D L Demets,et al. Group sequential procedures: calendar versus information time. , 1989, Statistics in medicine.
[17] W. Brannath,et al. Recursive Combination Tests , 2002 .
[18] A. Kopp-Schneider,et al. An Adaptive Group Sequential Phase II Design to Compare Treatments for Survival Endpoints in Rare Patient Entities , 2012, Journal of biopharmaceutical statistics.
[19] J. Denne,et al. Sample size recalculation using conditional power , 2001, Statistics in medicine.
[20] Anastasios A. Tsiatis,et al. Group sequential tests with censored survival data adjusting for covariates , 1985 .
[21] J M Lachin,et al. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. , 1986, Biometrics.
[22] C. Jennison,et al. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints † , 2011, Pharmaceutical statistics.
[23] Frank Bretz,et al. Twenty‐five years of confirmatory adaptive designs: opportunities and pitfalls , 2015, Statistics in medicine.
[24] Implementing type I & type II error spending for two-sided group sequential designs. , 2008, Contemporary clinical trials.
[25] Antje Jahn-Eimermacher,et al. Adaptive trial design: a general methodology for censored time to event data. , 2009, Contemporary clinical trials.
[26] P. Bauer,et al. Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.
[27] A. Tsiatis. A Large Sample Study of Cox's Regression Model , 1981 .
[28] W. Lehmacher,et al. Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.
[29] Helmut Schäfer,et al. Interim Design Modifications in Time-to-Event Studies , 2012 .
[30] J. S. D. Cani,et al. Group sequential designs using a family of type I error probability spending functions. , 1990, Statistics in medicine.
[31] H. Schäfer,et al. A general statistical principle for changing a design any time during the course of a trial , 2004, Statistics in medicine.